FDA Commissioner Andrew von Eschenbach has written Congress a letter asking for $275 million in increased funding for the agency, according to an article in the International Herald Tribune. Bowing to pressure from both Democrats and Republicans, the money will allow the opening of new foreign offices, increased inspections, and the construction of new databases to track drug hazards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.